Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

R.R. Donnelley Unveils Final Results Of Previously Announced Tender Offers

RELATED NEWS
Trade RRD now with 

R.R. Donnelley & Sons Co. (RRD: Quote) announced the expiration and final results of its offers to purchase for cash up to $450 million aggregate principal amount of its notes, including up to $350 million of its 4.95% Notes due April 1, 2014 and up to $100 million of its 5.50% Notes due May 15, 2015.

As of the Expiration Date, the aggregate principal amount of 2014 Notes tendered was $341.76 million, of which $340.53 million were tendered prior to 5:00 p.m., New York City time, on March 12, 2012 and were accepted for payment on the early tender settlement date on March 13, 2012.

RR Donnelley announced that it has accepted for payment all of the $1.23 million aggregate principal amount of 2014 Notes that had been validly tendered after the Early Tender Date and prior to the Expiration Date, and expects to make payment on such 2014 Notes on March 27. The holders of such 2014 Notes tendered after the Early Tender Date will not receive an early tender premium.

RR Donnelley also said it would not accept any additional 2015 Notes for purchase. Accordingly, any additional 2015 Notes that were tendered after the Early Tender Date were not considered validly tendered and will be returned.

Click here to receive FREE breaking news email alerts for R.R. Donnelley & Sons Company and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy. FCA US, until recently known as Chrysler, said Friday it is recalling 257,000 Dodge Ram pickups. The auto maker says the rear axle pinion nut on certain model year 2005 Dodge Ram 1500 trucks may loosen due to an undersized spline on the pinion gear. If the pinion nut loosens, the rear axle may... This medical device company has a very impressive track record of growing business over the past decade. increasing sales from $490.2 million in 2004 to $1.72 billion this year. The Silicone Hydrogel daily disposable lens portfolio constitutes a major avenue for growth.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.